Oliver Lagore Vanvalin Investment Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-15
Closed -$1.35K – 713
2024
Q3
$1.35K Hold
15
– – ﹤0.01% 603
2024
Q2
$1.18K Sell
15
-31
-67% -$2.54K ﹤0.01% 643
2024
Q1
$4.01K Buy
46
+22
+92% +$1.88K ﹤0.01% 540
2023
Q4
$1.98K Sell
24
-82
-77% -$6.25K ﹤0.01% 630
2023
Q3
$8.31K Sell
106
-2
-2% -$167 ﹤0.01% 468
2023
Q2
$9.52K Sell
108
-82
-43% -$7.06K ﹤0.01% 470
2023
Q1
$15.3K Sell
190
-3
-2% -$245 0.01% 323
2022
Q4
$15K Sell
193
-101
-34% -$8.19K 0.01% 311
2022
Q3
$24K Sell
294
-75
-20% -$6.74K 0.02% 234
2022
Q2
$33K Sell
369
-26
-7% -$2.63K 0.02% 216
2022
Q1
$43K Sell
395
-51,275
-99% -$5.42M 0.03% 184
2021
Q4
$5.34M Buy
+51,670
New +$5.98M 0.38% 40

Other funds holding MDT

Oliver Lagore Vanvalin Investment Group's MDT Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Medtronic (MDT) in Q4 2024, closing a stake of 15 shares — an estimated $1.35K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in MDT in Q4 2021 and held it in 12 quarters. The position peaked at $5.34M in Q4 2021. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 15 Medtronic shares in Q4 2024, an estimated $1.35K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Medtronic in Q4 2021 and held it in 12 quarters.
  • Oliver Lagore Vanvalin Investment Group's Medtronic position peaked at $5.34M in Q4 2021.
  • 2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.